Gepotidacin: A Novel Triazaacenaphthylene Antibacterial with Dual-Targeting Mechanism Against E. coli Gyrase and Topoisomerase IV – Medicine Innovates Share LinkedIn
Medicine Innovates Medicine Innovates: Delivering innovations in medicine to the world for better health and prosperity
